APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ramipril

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ramipril Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchRamipril Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Ramipril Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ramipril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ramipril Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ramipril Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ramipril market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ramipril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ramipril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ramipril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ramipril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ramipril include Novartis, King Pharmaceuticals, Westfield Pharma, Santa Cruz Biotechnology, Sanofi-Aventis, Pharmanova, Opsonin Pharma Limited., Lek and Krka, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ramipril, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ramipril, also provides the sales of main regions and countries. Of the upcoming market potential for Ramipril, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ramipril sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ramipril market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ramipril sales, projected growth trends, production technology, application and end-user industry.

Ramipril Segment by Company

Novartis

King Pharmaceuticals

Westfield Pharma

Santa Cruz Biotechnology

Sanofi-Aventis

Pharmanova

Opsonin Pharma Limited.

Lek

Krka

Hemofarm

Cemelog-BRS

Arrow Pharmaceuticals

Ramipril Segment by Type

Tablet Ramipril

Capsule Ramipril

Ramipril Segment by Application

Clinic

Hospital

Others

Ramipril Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ramipril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ramipril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ramipril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ramipril in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ramipril manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ramipril sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ramipril Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Ramipril Major Manufacturers Table 3. Capsule Ramipril Major Manufacturers Table 4. Global Ramipril Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Others Major Manufacturers Table 8. Ramipril Industry Trends Table 9. Ramipril Industry Drivers Table 10. Ramipril Industry Opportunities and Challenges Table 11. Ramipril Industry Restraints Table 12. Global Ramipril Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Ramipril Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Ramipril Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Ramipril Revenue Market Share by Region (2021-2026) Table 16. Global Ramipril Revenue Market Share by Region (2027-2032) Table 17. Global Ramipril Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Ramipril Sales by Region (2021-2026) & (k units) Table 19. Global Ramipril Sales by Region (2027-2032) & (k units) Table 20. Global Ramipril Sales Market Share by Region (2021-2026) Table 21. Global Ramipril Sales Market Share by Region (2027-2032) Table 22. Global Ramipril Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Ramipril Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Ramipril Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ramipril Sales Market Share by Manufacturers (2021-2026) Table 26. Global Ramipril Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Ramipril Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Ramipril Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Ramipril Manufacturers, Product Type & Application Table 30. Global Ramipril Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Ramipril by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Ramipril Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ramipril Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Ramipril Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Ramipril Revenue Market Share by Type (2021-2026) Table 37. Global Ramipril Revenue Market Share by Type (2027-2032) Table 38. Global Ramipril Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Ramipril Sales by Type (2021-2026) & (k units) Table 40. Global Ramipril Sales by Type (2027-2032) & (k units) Table 41. Global Ramipril Sales Market Share by Type (2021-2026) Table 42. Global Ramipril Sales Market Share by Type (2027-2032) Table 43. Global Ramipril Price by Type (2021-2026) & (US$/unit) Table 44. Global Ramipril Price by Type (2027-2032) & (US$/unit) Table 45. Global Ramipril Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Ramipril Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Ramipril Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Ramipril Revenue Market Share by Application (2021-2026) Table 49. Global Ramipril Revenue Market Share by Application (2027-2032) Table 50. Global Ramipril Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Ramipril Sales by Application (2021-2026) & (k units) Table 52. Global Ramipril Sales by Application (2027-2032) & (k units) Table 53. Global Ramipril Sales Market Share by Application (2021-2026) Table 54. Global Ramipril Sales Market Share by Application (2027-2032) Table 55. Global Ramipril Price by Application (2021-2026) & (US$/unit) Table 56. Global Ramipril Price by Application (2027-2032) & (US$/unit) Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Novartis Ramipril Product Portfolio Table 61. Novartis Recent Development Table 62. King Pharmaceuticals Company Information Table 63. King Pharmaceuticals Business Overview Table 64. King Pharmaceuticals Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. King Pharmaceuticals Ramipril Product Portfolio Table 66. King Pharmaceuticals Recent Development Table 67. Westfield Pharma Company Information Table 68. Westfield Pharma Business Overview Table 69. Westfield Pharma Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Westfield Pharma Ramipril Product Portfolio Table 71. Westfield Pharma Recent Development Table 72. Santa Cruz Biotechnology Company Information Table 73. Santa Cruz Biotechnology Business Overview Table 74. Santa Cruz Biotechnology Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Santa Cruz Biotechnology Ramipril Product Portfolio Table 76. Santa Cruz Biotechnology Recent Development Table 77. Sanofi-Aventis Company Information Table 78. Sanofi-Aventis Business Overview Table 79. Sanofi-Aventis Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Sanofi-Aventis Ramipril Product Portfolio Table 81. Sanofi-Aventis Recent Development Table 82. Pharmanova Company Information Table 83. Pharmanova Business Overview Table 84. Pharmanova Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Pharmanova Ramipril Product Portfolio Table 86. Pharmanova Recent Development Table 87. Opsonin Pharma Limited. Company Information Table 88. Opsonin Pharma Limited. Business Overview Table 89. Opsonin Pharma Limited. Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Opsonin Pharma Limited. Ramipril Product Portfolio Table 91. Opsonin Pharma Limited. Recent Development Table 92. Lek Company Information Table 93. Lek Business Overview Table 94. Lek Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Lek Ramipril Product Portfolio Table 96. Lek Recent Development Table 97. Krka Company Information Table 98. Krka Business Overview Table 99. Krka Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Krka Ramipril Product Portfolio Table 101. Krka Recent Development Table 102. Hemofarm Company Information Table 103. Hemofarm Business Overview Table 104. Hemofarm Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Hemofarm Ramipril Product Portfolio Table 106. Hemofarm Recent Development Table 107. Cemelog-BRS Company Information Table 108. Cemelog-BRS Business Overview Table 109. Cemelog-BRS Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Cemelog-BRS Ramipril Product Portfolio Table 111. Cemelog-BRS Recent Development Table 112. Arrow Pharmaceuticals Company Information Table 113. Arrow Pharmaceuticals Business Overview Table 114. Arrow Pharmaceuticals Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Arrow Pharmaceuticals Ramipril Product Portfolio Table 116. Arrow Pharmaceuticals Recent Development Table 117. North America Ramipril Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Ramipril Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Ramipril Sales by Type (2021-2026) & (k units) Table 120. North America Ramipril Sales by Type (2027-2032) & (k units) Table 121. North America Ramipril Sales Price by Type (2021-2026) & (US$/unit) Table 122. North America Ramipril Sales Price by Type (2027-2032) & (US$/unit) Table 123. North America Ramipril Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Ramipril Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Ramipril Sales by Application (2021-2026) & (k units) Table 126. North America Ramipril Sales by Application (2027-2032) & (k units) Table 127. North America Ramipril Sales Price by Application (2021-2026) & (US$/unit) Table 128. North America Ramipril Sales Price by Application (2027-2032) & (US$/unit) Table 129. North America Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Ramipril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Ramipril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Ramipril Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 133. North America Ramipril Sales by Country (2021-2026) & (k units) Table 134. North America Ramipril Sales by Country (2027-2032) & (k units) Table 135. North America Ramipril Sales Price by Country (2021-2026) & (US$/unit) Table 136. North America Ramipril Sales Price by Country (2027-2032) & (US$/unit) Table 137. United States Ramipril Revenue (2021-2032) & (US$ Million) Table 138. Canada Ramipril Revenue (2021-2032) & (US$ Million) Table 139. Mexico Ramipril Revenue (2021-2032) & (US$ Million) Table 140. Europe Ramipril Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Ramipril Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Ramipril Sales by Type (2021-2026) & (k units) Table 143. Europe Ramipril Sales by Type (2027-2032) & (k units) Table 144. Europe Ramipril Sales Price by Type (2021-2026) & (US$/unit) Table 145. Europe Ramipril Sales Price by Type (2027-2032) & (US$/unit) Table 146. Europe Ramipril Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Ramipril Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Ramipril Sales by Application (2021-2026) & (k units) Table 149. Europe Ramipril Sales by Application (2027-2032) & (k units) Table 150. Europe Ramipril Sales Price by Application (2021-2026) & (US$/unit) Table 151. Europe Ramipril Sales Price by Application (2027-2032) & (US$/unit) Table 152. Europe Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Ramipril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Ramipril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Ramipril Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 156. Europe Ramipril Sales by Country (2021-2026) & (k units) Table 157. Europe Ramipril Sales by Country (2027-2032) & (k units) Table 158. Europe Ramipril Sales Price by Country (2021-2026) & (US$/unit) Table 159. Europe Ramipril Sales Price by Country (2027-2032) & (US$/unit) Table 160. Germany Ramipril Revenue (2021-2032) & (US$ Million) Table 161. France Ramipril Revenue (2021-2032) & (US$ Million) Table 162. U.K. Ramipril Revenue (2021-2032) & (US$ Million) Table 163. Italy Ramipril Revenue (2021-2032) & (US$ Million) Table 164. Russia Ramipril Revenue (2021-2032) & (US$ Million) Table 165. Spain Ramipril Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Ramipril Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Ramipril Revenue (2021-2032) & (US$ Million) Table 168. Sweden Ramipril Revenue (2021-2032) & (US$ Million) Table 169. Poland Ramipril Revenue (2021-2032) & (US$ Million) Table 170. China Ramipril Revenue by Type (2021-2026) & (US$ Million) Table 171. China Ramipril Revenue by Type (2027-2032) & (US$ Million) Table 172. China Ramipril Sales by Type (2021-2026) & (k units) Table 173. China Ramipril Sales by Type (2027-2032) & (k units) Table 174. China Ramipril Sales Price by Type (2021-2026) & (US$/unit) Table 175. China Ramipril Sales Price by Type (2027-2032) & (US$/unit) Table 176. China Ramipril Revenue by Application (2021-2026) & (US$ Million) Table 177. China Ramipril Revenue by Application (2027-2032) & (US$ Million) Table 178. China Ramipril Sales by Application (2021-2026) & (k units) Table 179. China Ramipril Sales by Application (2027-2032) & (k units) Table 180. China Ramipril Sales Price by Application (2021-2026) & (US$/unit) Table 181. China Ramipril Sales Price by Application (2027-2032) & (US$/unit) Table 182. Asia Ramipril Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Ramipril Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Ramipril Sales by Type (2021-2026) & (k units) Table 185. Asia Ramipril Sales by Type (2027-2032) & (k units) Table 186. Asia Ramipril Sales Price by Type (2021-2026) & (US$/unit) Table 187. Asia Ramipril Sales Price by Type (2027-2032) & (US$/unit) Table 188. Asia Ramipril Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Ramipril Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Ramipril Sales by Application (2021-2026) & (k units) Table 191. Asia Ramipril Sales by Application (2027-2032) & (k units) Table 192. Asia Ramipril Sales Price by Application (2021-2026) & (US$/unit) Table 193. Asia Ramipril Sales Price by Application (2027-2032) & (US$/unit) Table 194. Asia Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Ramipril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Ramipril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Ramipril Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 198. Asia Ramipril Sales by Country (2021-2026) & (k units) Table 199. Asia Ramipril Sales by Country (2027-2032) & (k units) Table 200. Asia Ramipril Sales Price by Country (2021-2026) & (US$/unit) Table 201. Asia Ramipril Sales Price by Country (2027-2032) & (US$/unit) Table 202. Japan Ramipril Revenue (2021-2032) & (US$ Million) Table 203. South Korea Ramipril Revenue (2021-2032) & (US$ Million) Table 204. India Ramipril Revenue (2021-2032) & (US$ Million) Table 205. Australia Ramipril Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Ramipril Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Ramipril Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Ramipril Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Ramipril Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Ramipril Sales by Type (2021-2026) & (k units) Table 211. SAMEA Ramipril Sales by Type (2027-2032) & (k units) Table 212. SAMEA Ramipril Sales Price by Type (2021-2026) & (US$/unit) Table 213. SAMEA Ramipril Sales Price by Type (2027-2032) & (US$/unit) Table 214. SAMEA Ramipril Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Ramipril Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Ramipril Sales by Application (2021-2026) & (k units) Table 217. SAMEA Ramipril Sales by Application (2027-2032) & (k units) Table 218. SAMEA Ramipril Sales Price by Application (2021-2026) & (US$/unit) Table 219. SAMEA Ramipril Sales Price by Application (2027-2032) & (US$/unit) Table 220. SAMEA Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Ramipril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Ramipril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Ramipril Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 224. SAMEA Ramipril Sales by Country (2021-2026) & (k units) Table 225. SAMEA Ramipril Sales by Country (2027-2032) & (k units) Table 226. SAMEA Ramipril Sales Price by Country (2021-2026) & (US$/unit) Table 227. SAMEA Ramipril Sales Price by Country (2027-2032) & (US$/unit) Table 228. Brazil Ramipril Revenue (2021-2032) & (US$ Million) Table 229. Argentina Ramipril Revenue (2021-2032) & (US$ Million) Table 230. Chile Ramipril Revenue (2021-2032) & (US$ Million) Table 231. Colombia Ramipril Revenue (2021-2032) & (US$ Million) Table 232. Peru Ramipril Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Ramipril Revenue (2021-2032) & (US$ Million) Table 234. Israel Ramipril Revenue (2021-2032) & (US$ Million) Table 235. UAE Ramipril Revenue (2021-2032) & (US$ Million) Table 236. Turkey Ramipril Revenue (2021-2032) & (US$ Million) Table 237. Iran Ramipril Revenue (2021-2032) & (US$ Million) Table 238. Egypt Ramipril Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Ramipril Distributors List Table 242. Ramipril Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Ramipril Image Figure 2. Global Ramipril Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ramipril Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Ramipril Image Figure 5. Capsule Ramipril Image Figure 6. Global Ramipril Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ramipril Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Others Image Figure 11. Global Ramipril Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Ramipril Revenue (2021-2032) & (US$ Million) Figure 13. Global Ramipril Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Ramipril Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Ramipril Revenue Market Share by Region (2021-2032) Figure 16. Global Ramipril Sales (2021-2032) & (k units) Figure 17. Global Ramipril Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Ramipril Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Ramipril Sales YoY (2021-2032) & (k units) Figure 20. Europe Ramipril Sales YoY (2021-2032) & (k units) Figure 21. China Ramipril Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Ramipril Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Ramipril Sales YoY (2021-2032) & (k units) Figure 24. Global Ramipril Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Ramipril Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Ramipril Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Ramipril Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Ramipril Revenue Market Share by Type (2021-2032) Figure 30. Global Ramipril Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Ramipril Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Ramipril Sales Market Share by Type (2021-2032) Figure 33. Global Ramipril Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Ramipril Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Ramipril Revenue Market Share by Application (2021-2032) Figure 36. Global Ramipril Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Ramipril Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Ramipril Sales Market Share by Application (2021-2032) Figure 39. North America Ramipril Revenue Share by Type (2021-2032) Figure 40. North America Ramipril Sales Share by Type (2021-2032) Figure 41. North America Ramipril Revenue Share by Application (2021-2032) Figure 42. North America Ramipril Sales Share by Application (2021-2032) Figure 43. North America Ramipril Revenue Share by Country (2021-2032) Figure 44. North America Ramipril Sales Share by Country (2021-2032) Figure 45. Europe Ramipril Revenue Share by Type (2021-2032) Figure 46. Europe Ramipril Sales Share by Type (2021-2032) Figure 47. Europe Ramipril Revenue Share by Application (2021-2032) Figure 48. Europe Ramipril Sales Share by Application (2021-2032) Figure 49. Europe Ramipril Revenue Share by Country (2021-2032) Figure 50. Europe Ramipril Sales Share by Country (2021-2032) Figure 51. China Ramipril Revenue Share by Type (2021-2032) Figure 52. China Ramipril Sales Share by Type (2021-2032) Figure 53. China Ramipril Revenue Share by Application (2021-2032) Figure 54. China Ramipril Sales Share by Application (2021-2032) Figure 55. Asia Ramipril Revenue Share by Type (2021-2032) Figure 56. Asia Ramipril Sales Share by Type (2021-2032) Figure 57. Asia Ramipril Revenue Share by Application (2021-2032) Figure 58. Asia Ramipril Sales Share by Application (2021-2032) Figure 59. Asia Ramipril Revenue Share by Country (2021-2032) Figure 60. Asia Ramipril Sales Share by Country (2021-2032) Figure 61. SAMEA Ramipril Revenue Share by Type (2021-2032) Figure 62. SAMEA Ramipril Sales Share by Type (2021-2032) Figure 63. SAMEA Ramipril Revenue Share by Application (2021-2032) Figure 64. SAMEA Ramipril Sales Share by Application (2021-2032) Figure 65. SAMEA Ramipril Revenue Share by Country (2021-2032) Figure 66. SAMEA Ramipril Sales Share by Country (2021-2032) Figure 67. Ramipril Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ramipril Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet Ramipril
  • Capsule Ramipril
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Novartis
  • King Pharmaceuticals
  • Westfield Pharma
  • Santa Cruz Biotechnology
  • Sanofi-Aventis
  • Pharmanova
  • Opsonin Pharma Limited.
  • Lek
  • Krka
  • Hemofarm
  • Cemelog-BRS
  • Arrow Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ramipril Market by Type
  3. 1.2.1 Global Ramipril Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet Ramipril
  5. 1.2.3 Capsule Ramipril
  6. 1.3 Ramipril Market by Application
  7. 1.3.1 Global Ramipril Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ramipril Market Dynamics
  1. 2.1 Ramipril Industry Trends
  2. 2.2 Ramipril Industry Drivers
  3. 2.3 Ramipril Industry Opportunities and Challenges
  4. 2.4 Ramipril Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ramipril Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ramipril Revenue by Region
  3. 3.2.1 Global Ramipril Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ramipril Revenue by Region (2021-2026)
  5. 3.2.3 Global Ramipril Revenue by Region (2027-2032)
  6. 3.2.4 Global Ramipril Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ramipril Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ramipril Sales by Region
  9. 3.4.1 Global Ramipril Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ramipril Sales by Region (2021-2026)
  11. 3.4.3 Global Ramipril Sales by Region (2027-2032)
  12. 3.4.4 Global Ramipril Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ramipril Revenue by Manufacturers
  2. 4.1.1 Global Ramipril Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ramipril Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ramipril Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ramipril Sales by Manufacturers
  6. 4.2.1 Global Ramipril Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ramipril Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ramipril Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ramipril Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ramipril Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ramipril Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ramipril Manufacturers, Product Type & Application
  13. 4.7 Global Ramipril Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ramipril Market CR5 and HHI
  16. 4.8.2 2025 Ramipril Tier 1, Tier 2, and Tier 3
5 Ramipril Market by Type
  1. 5.1 Global Ramipril Revenue by Type
  2. 5.1.1 Global Ramipril Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ramipril Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ramipril Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ramipril Sales by Type
  6. 5.2.1 Global Ramipril Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ramipril Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Ramipril Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ramipril Price by Type
6 Ramipril Market by Application
  1. 6.1 Global Ramipril Revenue by Application
  2. 6.1.1 Global Ramipril Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ramipril Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ramipril Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ramipril Sales by Application
  6. 6.2.1 Global Ramipril Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ramipril Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Ramipril Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ramipril Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Ramipril Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 King Pharmaceuticals
  8. 7.2.1 King Pharmaceuticals Company Information
  9. 7.2.2 King Pharmaceuticals Business Overview
  10. 7.2.3 King Pharmaceuticals Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 King Pharmaceuticals Ramipril Product Portfolio
  12. 7.2.5 King Pharmaceuticals Recent Developments
  13. 7.3 Westfield Pharma
  14. 7.3.1 Westfield Pharma Company Information
  15. 7.3.2 Westfield Pharma Business Overview
  16. 7.3.3 Westfield Pharma Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Westfield Pharma Ramipril Product Portfolio
  18. 7.3.5 Westfield Pharma Recent Developments
  19. 7.4 Santa Cruz Biotechnology
  20. 7.4.1 Santa Cruz Biotechnology Company Information
  21. 7.4.2 Santa Cruz Biotechnology Business Overview
  22. 7.4.3 Santa Cruz Biotechnology Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Santa Cruz Biotechnology Ramipril Product Portfolio
  24. 7.4.5 Santa Cruz Biotechnology Recent Developments
  25. 7.5 Sanofi-Aventis
  26. 7.5.1 Sanofi-Aventis Company Information
  27. 7.5.2 Sanofi-Aventis Business Overview
  28. 7.5.3 Sanofi-Aventis Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi-Aventis Ramipril Product Portfolio
  30. 7.5.5 Sanofi-Aventis Recent Developments
  31. 7.6 Pharmanova
  32. 7.6.1 Pharmanova Company Information
  33. 7.6.2 Pharmanova Business Overview
  34. 7.6.3 Pharmanova Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pharmanova Ramipril Product Portfolio
  36. 7.6.5 Pharmanova Recent Developments
  37. 7.7 Opsonin Pharma Limited.
  38. 7.7.1 Opsonin Pharma Limited. Company Information
  39. 7.7.2 Opsonin Pharma Limited. Business Overview
  40. 7.7.3 Opsonin Pharma Limited. Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Opsonin Pharma Limited. Ramipril Product Portfolio
  42. 7.7.5 Opsonin Pharma Limited. Recent Developments
  43. 7.8 Lek
  44. 7.8.1 Lek Company Information
  45. 7.8.2 Lek Business Overview
  46. 7.8.3 Lek Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lek Ramipril Product Portfolio
  48. 7.8.5 Lek Recent Developments
  49. 7.9 Krka
  50. 7.9.1 Krka Company Information
  51. 7.9.2 Krka Business Overview
  52. 7.9.3 Krka Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Krka Ramipril Product Portfolio
  54. 7.9.5 Krka Recent Developments
  55. 7.10 Hemofarm
  56. 7.10.1 Hemofarm Company Information
  57. 7.10.2 Hemofarm Business Overview
  58. 7.10.3 Hemofarm Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hemofarm Ramipril Product Portfolio
  60. 7.10.5 Hemofarm Recent Developments
  61. 7.11 Cemelog-BRS
  62. 7.11.1 Cemelog-BRS Company Information
  63. 7.11.2 Cemelog-BRS Business Overview
  64. 7.11.3 Cemelog-BRS Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Cemelog-BRS Ramipril Product Portfolio
  66. 7.11.5 Cemelog-BRS Recent Developments
  67. 7.12 Arrow Pharmaceuticals
  68. 7.12.1 Arrow Pharmaceuticals Company Information
  69. 7.12.2 Arrow Pharmaceuticals Business Overview
  70. 7.12.3 Arrow Pharmaceuticals Ramipril Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Arrow Pharmaceuticals Ramipril Product Portfolio
  72. 7.12.5 Arrow Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Ramipril Market Size by Type
  2. 8.1.1 North America Ramipril Revenue by Type (2021-2032)
  3. 8.1.2 North America Ramipril Sales by Type (2021-2032)
  4. 8.1.3 North America Ramipril Price by Type (2021-2032)
  5. 8.2 North America Ramipril Market Size by Application
  6. 8.2.1 North America Ramipril Revenue by Application (2021-2032)
  7. 8.2.2 North America Ramipril Sales by Application (2021-2032)
  8. 8.2.3 North America Ramipril Price by Application (2021-2032)
  9. 8.3 North America Ramipril Market Size by Country
  10. 8.3.1 North America Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ramipril Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ramipril Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ramipril Market Size by Type
  2. 9.1.1 Europe Ramipril Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ramipril Sales by Type (2021-2032)
  4. 9.1.3 Europe Ramipril Price by Type (2021-2032)
  5. 9.2 Europe Ramipril Market Size by Application
  6. 9.2.1 Europe Ramipril Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ramipril Sales by Application (2021-2032)
  8. 9.2.3 Europe Ramipril Price by Application (2021-2032)
  9. 9.3 Europe Ramipril Market Size by Country
  10. 9.3.1 Europe Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ramipril Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ramipril Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ramipril Market Size by Type
  2. 10.1.1 China Ramipril Revenue by Type (2021-2032)
  3. 10.1.2 China Ramipril Sales by Type (2021-2032)
  4. 10.1.3 China Ramipril Price by Type (2021-2032)
  5. 10.2 China Ramipril Market Size by Application
  6. 10.2.1 China Ramipril Revenue by Application (2021-2032)
  7. 10.2.2 China Ramipril Sales by Application (2021-2032)
  8. 10.2.3 China Ramipril Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ramipril Market Size by Type
  2. 11.1.1 Asia Ramipril Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ramipril Sales by Type (2021-2032)
  4. 11.1.3 Asia Ramipril Price by Type (2021-2032)
  5. 11.2 Asia Ramipril Market Size by Application
  6. 11.2.1 Asia Ramipril Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ramipril Sales by Application (2021-2032)
  8. 11.2.3 Asia Ramipril Price by Application (2021-2032)
  9. 11.3 Asia Ramipril Market Size by Country
  10. 11.3.1 Asia Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ramipril Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ramipril Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ramipril Market Size by Type
  2. 12.1.1 SAMEA Ramipril Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ramipril Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ramipril Price by Type (2021-2032)
  5. 12.2 SAMEA Ramipril Market Size by Application
  6. 12.2.1 SAMEA Ramipril Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ramipril Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ramipril Price by Application (2021-2032)
  9. 12.3 SAMEA Ramipril Market Size by Country
  10. 12.3.1 SAMEA Ramipril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ramipril Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ramipril Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ramipril Value Chain Analysis
  2. 13.1.1 Ramipril Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ramipril Production Mode & Process
  6. 13.2 Ramipril Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ramipril Distributors
  9. 13.2.3 Ramipril Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst